New research shows that gut bacteria and metabolites may reveal early warning signs of multiple gastrointestinal diseases. Scientists have uncovered biological signals in the gut that may make it ...
Research shows that eating a plant-based diet may offer protective benefits for heart health and prevention against certain ...
Chronically high levels of insulin and inflammation are key features of obesity and metabolic syndrome, which mediate cancer ...
Research conducted by Gustave Roussy will help StarkAge move STX-01, an antibody-drug conjugate targeting senescent cells, toward clinical trials.
Advanced gastroesophageal adenocarcinoma (GEA) with HER2 positivity has long presented significant treatment challenges, with first-line therapies offering limited survival benefits despite advances ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. /CNW/ — Equity-Insider.com News Commentary – The global oncology therapy market is charging toward a massive $668 ...
A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing skin and joint symptoms, requiring ongoing ...
A new study found that lifetime alcohol consumption can significantly raise the risk of developing colorectal cancer.
Conducted under a research agreement with Gustave Roussy and its technology transfer affiliate, Gustave Roussy Transfert, this collaboration will combine StarkAge’s expertise in senescence biology ...
A fit and healthy man in his 30s has revealed the initial symptoms he experienced before being diagnosed with small bowel adenocarcinoma ...
AKTX-102 is a first-in-class ADC that combines a novel CEACAM5-targeting antibody construct with Akari’s proprietary PH1 ...
The reported increase of the early onset of multiple types of cancer (defined as a cancer diagnosis prior to 50 years of age) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results